Akathisia is a medication-induced condition defined by an overwhelming inner restlessness and compulsion to move that is frequently misidentified as anxiety or psychiatric deterioration, and recognizing its distinct symptoms and medication triggers helps individuals seek accurate diagnosis and the professional therapeutic support needed to manage its significant emotional and functional impact.
The unbearable restlessness you feel after starting a new medication is not always your mental health getting worse. It could be akathisia, a medication-induced condition so routinely misread that it leads to the wrong treatment, and knowing its name could change the direction of your care entirely.
What is akathisia?
Akathisia is a medication-induced condition defined by an overwhelming internal sense of restlessness and an urgent, unrelenting need to move. As a neuropsychiatric syndrome characterized by psychomotor restlessness, it has two distinct components that often appear together. The first is subjective: an inner dread, a deep discomfort, and an inability to feel settled in your own body. The second is objective: the visible behaviors that result, like pacing, rocking, or constantly shifting your weight.
The word itself traces back to the Greek akathízein, meaning inability to sit, a detail first formalized in the medical literature by Ladislav Haskovec. But the name undersells the experience. This is not ordinary fidgeting or the low-level restlessness you might feel after too much coffee. People who experience akathisia often describe it as a torment that exists beneath the skin, something they cannot escape no matter how much they move.
That quality makes akathisia genuinely hard to put into words. Many people mistake the inner restlessness for anxiety symptoms, and some clinicians do the same. Because patients struggle to articulate what they feel, and because the condition can look like agitation or worsening psychiatric symptoms, akathisia is frequently missed or misattributed.
By the end of this article, you will have a clearer picture of what akathisia is, what causes it, and how to describe your experience to a prescriber in a way that gets taken seriously.
What inner restlessness actually feels like
Akathisia symptoms are notoriously difficult to put into words, and that difficulty is not a personal failing. It is one of the condition’s defining features. Many people spend weeks searching for the right description before landing on something that even partially captures it. If you have struggled to explain what is happening inside your body, you are not alone, and that struggle itself is a clue.
Two distinct sensations people describe
The internal experience tends to fall into one of two broad patterns, though some people feel both at once. The first is a crawling-under-the-skin sensation, almost like something is moving just beneath the surface, relentless and impossible to scratch away. The second is more electric: a buzzing or vibrating feeling that radiates from deep inside the muscles or bones, as if the body is humming at a frequency it cannot shut off. Neither sensation is painful in the traditional sense, but both are profoundly distressing and impossible to ignore.
The mental and physical pull working together
Akathisia is not purely physical restlessness. There is a mental dread that runs alongside it, a low-grade sense of impending doom or the feeling that you need to escape your own body. Your mind cannot settle, even when you want it to. Thoughts scatter. Sitting still feels not just uncomfortable but almost unbearable.
The physical urge component is equally relentless. Legs demand movement. The compulsion to pace, rock, or shift weight offers only a few seconds of partial relief before the pressure rebuilds. Real-world examples make this clearer: you cannot sit through a full meal, you get out of bed repeatedly at night without knowing why, or you lose the thread of a conversation because the internal pull to move overrides your ability to concentrate.
Why your experience is likely worse than it looks
People around you may notice fidgeting or pacing and underestimate what is actually happening. The visible signs of akathisia rarely match the internal intensity. This gap is exactly why self-reporting matters so much. Only you can describe the quality of what you feel, and giving it a name, even an imperfect one, is the first step toward getting the right support.
What causes akathisia?
Most cases of akathisia trace back to one core mechanism: medications that block dopamine D2 receptors in the basal ganglia, a region deep in the brain that helps regulate movement and reward. When those receptors are disrupted, the brain’s motor control circuitry misfires, producing the relentless restlessness that defines akathisia. Understanding which drug classes carry this risk is one of the most important steps in recognizing medication-induced akathisia early.
Antipsychotic medications
First-generation antipsychotics, sometimes called typical antipsychotics, carry the highest known risk. Medications like haloperidol and chlorpromazine were so reliably linked to akathisia that they helped define the condition in psychiatric literature decades ago. The strong D2 receptor blockade these drugs produce makes akathisia one of their most common and distressing side effects.
Second-generation antipsychotics, often called atypical antipsychotics, were once thought to pose a lower risk, but that picture is more complicated. Medications including risperidone, olanzapine, and aripiprazole are all well-documented akathisia causes. Aripiprazole is a partial dopamine agonist, meaning it activates D2 receptors only partially rather than blocking them outright, yet it remains frequently implicated. Research on akathisia incidence with aripiprazole and second-generation antipsychotics confirms that the pathophysiology is multifactorial and that no atypical antipsychotic should be considered low-risk by default.
Antidepressants and anti-nausea drugs
Antidepressants are an underrecognized cause of akathisia, particularly in the early weeks of treatment or after a dose increase. SSRIs such as fluoxetine and sertraline, along with the SNRI venlafaxine, have all been associated with akathisia symptoms. Because these medications are so widely prescribed for depression treatment and anxiety, clinicians and patients alike may not immediately connect new restlessness to the medication.
Antiemetics, the drugs used to treat nausea and vomiting, are another frequently missed cause. Metoclopramide and prochlorperazine both block dopamine receptors and can trigger akathisia even after short-term use. Because these medications are often prescribed outside psychiatric settings, by emergency physicians or gastroenterologists, the connection to akathisia is easy to overlook. Calcium channel blockers and certain other non-psychiatric medications have also been documented as rarer causes.
Risk factors that increase vulnerability
Not everyone who takes a dopamine-blocking medication develops akathisia. Several factors raise the odds considerably. Evidence on risk factors for akathisia with second-generation antipsychotics points to rapid dose escalation, higher overall doses, older age, iron deficiency, and a personal history of prior akathisia as key vulnerabilities. Taking multiple dopamine-affecting agents at the same time compounds the risk further.
Withdrawal akathisia is also worth knowing about. Abruptly stopping dopaminergic medications or benzodiazepines can trigger akathisia as the brain recalibrates, making gradual tapering under medical supervision especially important.
Types of akathisia
Not all akathisia looks the same, and the different types of akathisia vary in when they appear, how long they last, and how well they respond to treatment. Knowing which type you may be experiencing is genuinely useful information, and it starts with paying attention to timing.
Acute akathisia is the most common form. It develops within days to weeks of starting a new medication or increasing an existing dose. Because it appears so soon after a medication change, it is usually easier to identify and tends to respond well to intervention.
Tardive akathisia develops after months or years of medication use. This form is more treatment-resistant and can persist even after the medication that caused it is stopped, which makes early recognition especially important.
Withdrawal akathisia emerges when a medication is reduced or discontinued. This type is easy to misread: the restlessness and distress can look a lot like a return of the original condition being treated, rather than a reaction to stopping the drug.
Chronic akathisia is defined by duration rather than cause. If symptoms persist for more than three months, the akathisia is considered chronic, regardless of which subtype triggered it.
Why the type matters when you talk to your prescriber
The single most useful thing you can bring to a prescriber appointment is a clear timeline. When did symptoms start? Did anything change with your medication around that time? Was a dose increased, reduced, or stopped? That context helps your prescriber identify the subtype quickly and decide on the most appropriate next step.
Is this akathisia or something else?
Akathisia shares surface-level symptoms with several other conditions, which is part of why akathisia frequently goes unrecognized and underreported. Getting the distinction right matters, because the wrong label can lead to the wrong treatment. The four most common sources of confusion are generalized anxiety, restless leg syndrome (RLS), psychomotor agitation, and tardive dyskinesia.
Akathisia vs. anxiety
At first glance, akathisia and generalized anxiety can look almost identical. Both involve distress, an inability to settle, and a sense that something is deeply wrong. The differences, though, are meaningful.
Akathisia produces an inner restlessness and whole-body dread that is physical as much as it is emotional. Anxiety tends to center on worry, apprehension, and mental preoccupation, often with chest tightness or a racing heart. Crucially, akathisia tracks medication changes closely: it tends to appear shortly after starting a new drug, increasing a dose, or stopping one. Anxiety often predates medication entirely. Movement offers people with akathisia only brief, partial relief before the feeling rushes back. For people with anxiety, pacing usually does not help at all.
Akathisia vs. restless leg syndrome
Restless leg syndrome (RLS) involves an uncomfortable crawling or pulling sensation that drives the urge to move, so the overlap with akathisia is real. The key differences come down to location, timing, and relief.
RLS is leg-specific. Akathisia is generalized, a whole-body discomfort without a clear focal point. RLS reliably worsens in the evening and at night, often predates any medication use, and responds well to walking or stretching. Akathisia can be constant or tied to when a dose peaks or wears off, and movement brings only fleeting relief before the restlessness returns. If your symptoms are confined to your legs and ease significantly with a short walk, RLS is a more likely explanation.
Akathisia vs. psychomotor agitation and tardive dyskinesia
Psychomotor agitation, the visible restlessness and irritability that can accompany a mood episode, shares akathisia’s outward appearance. The distinction lies in context: psychomotor agitation is part of the mood episode itself, not a medication side effect. Akathisia is medication-induced by definition in this context, and it carries a prominent inner dread that psychomotor agitation does not always include.
Tardive dyskinesia (TD) is different in kind. It involves involuntary, repetitive movements, most often in the face, jaw, tongue, and limbs, rather than a driven urge to move. TD and akathisia can coexist, but they are separate conditions. One important clinical clue: reducing a medication dose tends to improve akathisia, while it can temporarily worsen tardive dyskinesia. Withdrawal from certain medications can also trigger akathisia even as TD symptoms shift, which makes akathisia diagnosis especially tricky during medication transitions.
How akathisia is diagnosed
There is no blood test or brain scan that can confirm akathisia. An akathisia diagnosis is clinical, meaning it depends on what you report feeling combined with what a clinician directly observes. This makes the process more personal than many medical evaluations, and it also means your own words carry real diagnostic weight.
Your medication history is one of the strongest clues a clinician has. If your symptoms appeared shortly after starting, stopping, or changing a medication, that timing is a significant red flag pointing toward akathisia rather than a separate condition.
The Barnes Akathisia Rating Scale explained
The most widely used standardized tool for akathisia diagnosis is the Barnes Akathisia Rating Scale (BARS), supported by clinical guidelines for assessing akathisia using validated rating scales. It scores three areas on a 0–3 scale, plus an overall clinical impression:
- Objective restlessness: The clinician watches you sit and stand, looking for visible fidgeting, shifting, or inability to stay still
- Subjective awareness: You describe how aware you are of an inner sense of restlessness
- Subjective distress: You rate how distressing that feeling is for you
The full picture comes from combining what the clinician sees with what you experience internally.
Many prescribers do not routinely screen for akathisia, even when it is a real possibility. You can ask for a BARS assessment by name. Requesting a specific, validated tool is a reasonable and informed step, and any clinician familiar with akathisia will recognize it immediately.
Why akathisia gets mistaken for worsening illness, and how to advocate for yourself
Akathisia misdiagnosis follows a painful and well-documented cycle. You report feeling agitated, restless, or deeply distressed. Your prescriber, unable to see the inner experience you are describing, interprets it as your underlying condition getting worse. The dose goes up. The akathisia intensifies. The cycle repeats. Research confirms that this pattern carries significant clinical cost, meaning real harm can result from akathisia being repeatedly misread as psychiatric deterioration.